ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,200.00
      -0.40%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.765
      0.27%
      Bitcoin
      62,618.22
      -0.37%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Enanta Pharmaceuticals Inc (ENTA)

      7. Enanta Pharmaceuticals Inc (ENTA) News

      ENTA

      Enanta Pharmaceuticals (ENTA)

      Enanta Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ENTA
      DateTimeSourceHeadlineSymbolCompany
      07/29/20223:35PMTipRanksJMP Securities Reiterates Their Buy Rating on Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      07/29/20227:00AMBusiness WireEnanta Pharmaceuticals Announces Positive Data from a Phase 1 Clinical Study of EDP-235, its Oral 3CL Protease Inhibitor Designed for the Treatment of COVID-19NASDAQ:ENTAEnanta Pharmaceuticals Inc
      07/08/202210:07PMTipRanksRBC Capital Sticks to Its Hold Rating for Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/23/202210:46PMTipRanksAnalysts’ Top Healthcare Picks: Enanta Pharmaceuticals (ENTA), Cellectis SA (CLLS)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/22/20226:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/21/20225:47PMDow Jones NewsEnanta: Filed Patent Infringement Suit Against Pfizer Over PaxlovidNASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/21/20224:50PMBusiness WireEnanta Pharmaceuticals Files Patent Infringement Suit Against PfizerNASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/21/20224:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/08/20227:00AMBusiness WireEnanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022NASDAQ:ENTAEnanta Pharmaceuticals Inc
      06/02/20227:00AMBusiness WireEnanta Pharmaceuticals to Participate in Two Investor Conferences in JuneNASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/19/202211:46PMTipRanksEvercore ISI Maintains a Sell Rating on Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/19/202212:45AMTipRanksJMP Securities Reaffirms Their Buy Rating on Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/18/20224:01PMBusiness WireEnanta Pharmaceuticals Reports Topline Data from the RSVP Study of EDP-938 in Otherwise Healthy Adults with Community-Acquired Respiratory Syncytial Virus (RSV)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/11/202212:30AMTipRanksRobert W. Baird Keeps Their Buy Rating on Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/10/20228:44AMTipRanksEnanta Pharmaceuticals (ENTA) Receives a Hold from SVB SecuritiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/10/20222:15AMTipRanksAnalysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Precision BioSciences (DTIL)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/09/20224:41PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/09/20224:13PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/09/20224:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/09/20224:01PMBusiness WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/04/20228:51AMTipRanksEnanta Pharmaceuticals (ENTA) Gets a Hold Rating from SVB SecuritiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
      05/02/20227:00AMBusiness WireEnanta Pharmaceuticals to Host Conference Call on May 9 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2022NASDAQ:ENTAEnanta Pharmaceuticals Inc
      04/07/20229:53PMTipRanksRBC Capital Keeps a Hold Rating on Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/30/202212:15AMTipRanksAnalysts Are Bullish on Top Healthcare Stocks: Cormedix (CRMD), Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/29/20227:00AMBusiness WireEnanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-235, its Oral 3CL Protease Inhibitor Specifically Designed for the Treatment and Prevention of COVID-19NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/22/20225:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/18/20228:18AMTipRanksLeerink Partners Sticks to Its Hold Rating for Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/11/202210:54PMTipRanksEvercore ISI Maintains a Sell Rating on Enanta Pharmaceuticals (ENTA)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/09/20224:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      03/08/20224:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ENTA